Medicare Enrolled
Dr. Geetha Varma, M.D
Hematology & Oncology · Salinas, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Varma from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Varma?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Varma
Dr. Geetha Varma is a hematology & oncology specialist in Salinas, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Varma performed 1,596 Medicare services across 746 unique beneficiaries.
Between the years covered by Open Payments, Dr. Varma received a total of $5,354 from 64 pharmaceutical and/or device companies across 238 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Varma is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 43% volume in CA
$5,354 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,596
Medicare services
Top 43% in CA for hematology & oncology
746
Unique beneficiaries
$98
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~80 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,022 | $102 | $250 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
302 | $64 | $167 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
65 | $153 | $336 |
| New patient office visit, complex (60-74 min) | 64 | $183 | $480 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
62 | $67 | $173 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
33 | $122 | $385 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
32 | $97 | $248 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
16 | $20 | $49 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$5,354
Total received (2018-2024)
Avg $765/year across 7 years
Top 42% in CA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
64
Companies
238
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,880 (91.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$475 (8.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,505
2023
$1,437
2022
$1,051
2021
$338
2020
$49
2019
$234
2018
$741
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Daiichi Sankyo Inc.
$186
Janssen Biotech, Inc.
$170
Astellas Pharma US Inc
$111
AstraZeneca Pharmaceuticals LP
$107
Novartis Pharmaceuticals Corporation
$71
Aveo Pharmaceuticals, Inc.
$64
PFIZER INC.
$64
GlaxoSmithKline, LLC.
$51
Eisai Inc.
$51
EMD Serono, Inc.
$50
SERVIER PHARMACEUTICALS LLC
$46
Genentech USA, Inc.
$44
SpringWorks Therapeutics, Inc.
$44
JAZZ PHARMACEUTICALS INC.
$39
Merck Sharp & Dohme LLC
$34
Takeda Pharmaceuticals U.S.A., Inc.
$32
ABBVIE INC.
$31
Stemline Therapeutics Inc.
$30
PUMA BIOTECHNOLOGY, INC.
$30
Exelixis Inc.
$27
BeiGene USA, Inc.
$23
Gilead Sciences, Inc.
$21
Genmab U.S., Inc.
$20
Celgene Corporation
$20
Myriad Genetic Laboratories, Inc.
$20
Apellis Pharmaceuticals, Inc.
$19
Deciphera Pharmaceuticals Inc.
$19
PharmaEssentia USA Corporation
$18
SOBI, INC
$17
RECORDATI_RARE_DISEASES_INC.
$16
ImmunoGen, Inc.
$16
Lilly USA, LLC
$14
Top 3 companies account for 31.0% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$455
Myriad Genetic Laboratories, Inc.
$390
Janssen Biotech, Inc.
$345
Novartis Pharmaceuticals Corporation
$343
PFIZER INC.
$304
Daiichi Sankyo Inc.
$264
Amgen Inc.
$234
Exelixis Inc.
$157
Astellas Pharma US Inc
$146
Foundation Medicine, Inc.
$145
E.R. Squibb & Sons, L.L.C.
$109
AVEO Pharmaceuticals, Inc.
$108
Eisai Inc.
$102
SANOFI-AVENTIS U.S. LLC
$100
Lilly USA, LLC
$100
Gilead Sciences, Inc.
$99
GlaxoSmithKline, LLC.
$98
Celgene Corporation
$92
ABBVIE INC.
$87
Genentech USA, Inc.
$85
Stemline Therapeutics Inc.
$84
EISAI INC.
$82
Aveo Pharmaceuticals, Inc.
$81
EMD Serono, Inc.
$70
Kite Pharma, Inc.
$69
Kyowa Kirin, Inc.
$60
Seagen Inc.
$58
Regeneron Healthcare Solutions, Inc.
$55
TAIHO ONCOLOGY, INC.
$51
PharmaEssentia USA Corporation
$50
Janssen Pharmaceuticals, Inc
$49
SERVIER PHARMACEUTICALS LLC
$46
Ipsen Biopharmaceuticals, Inc
$44
SpringWorks Therapeutics, Inc.
$44
GENZYME CORPORATION
$42
Sobi, Inc
$39
JAZZ PHARMACEUTICALS INC.
$39
BeiGene USA, Inc.
$38
Seattle Genetics, Inc.
$37
Incyte Corporation
$36
Merck Sharp & Dohme LLC
$34
Taiho Oncology, Inc.
$33
Takeda Pharmaceuticals U.S.A., Inc.
$32
Karyopharm Therapeutics Inc.
$31
PUMA BIOTECHNOLOGY, INC.
$30
Helsinn Therapeutics (U.S.), Inc.
$29
Blueprint Medicines Corporation
$25
AbbVie, Inc.
$24
ARRAY BIOPHARMA INC
$23
Coherus Biosciences Inc.
$22
CTI BioPharma Corp.
$21
Clovis Oncology, Inc.
$20
Genmab U.S., Inc.
$20
Apellis Pharmaceuticals, Inc.
$19
Deciphera Pharmaceuticals Inc.
$19
Rigel Pharmaceuticals, Inc.
$18
SOBI, INC
$17
RECORDATI_RARE_DISEASES_INC.
$16
ImmunoGen, Inc.
$16
Mirati Therapeutics, Inc.
$15
TESARO, Inc.
$14
Agios Pharmaceuticals, Inc.
$14
Bayer Healthcare Pharmaceuticals Inc.
$13
Myovant Sciences Inc.
$13
Top 3 companies account for 22.2% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AKYNZEO · ALUNBRIG · AYVAKIT · BESREMI · BOSULIF · BRAFTOVI · BRUKINSA · CABOMETYX · CALQUENCE · CARVYKTI · CYRAMZA · Cabometyx · Cresemba · DARZALEX · DOPTELET · ELAHERE · ELIQUIS · ELREXFIO · ELZONRIS · ENHERTU · ERLEADA · Empaveli · Enhertu · Epkinly · FOTIVDA · FOUNDATIONONE · IBRANCE · IDHIFA · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Itovebi · JAKAFI · JEMPERLI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LONSURF · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · MYLOTARG · Nplate · OGSIVEO · OPDIVO · ORGOVYX · Orserdu · PADCEV · PLUVICTO · POTELIGEO · PRECISETUMOR · Pomalyst · Prolia · QINLOCK · REBLOZYL · Rezlidhia · Rituxan · Rubraca · SANCUSO · SARCLISA · SCEMBLIX · SOMATULINE DEPOT · SPRYCEL · SYLVANT · Stivarga · TABRECTA · TAGRISSO · TASIGNA · TEVIMBRA · TIVDAK · Tecentriq · Trodelvy · Udenyca · VENCLEXTA · VERZENIO · VONJO · VOTRIENT · Venclexta · Vonjo · XALKORI · XARELTO · XGEVA · XPOVIO · Xospata · Xtandi · Yescarta · ZEJULA · ZIIHERA · ZYTIGA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (91%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Hematology & oncology specialists within 10 mi
13
Per 100K population
3.0
County median income
$94,486
Nearest hospital
SALINAS VALLEY MEMORIAL HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Varma is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Varma experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Varma performed 1,022 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Varma receive payments from pharmaceutical companies?
Yes. Dr. Varma received a total of $5,354 from 64 companies across 238 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Varma's costs compare to other hematology & oncology specialists in Salinas?
Dr. Varma's average Medicare payment per service is $98. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Varma) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Salinas
Browse hematology & oncology specialists in Salinas ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in CA
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in CA
Which CA hematology & oncology specialists receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Myriad Genetic Laboratories, Inc. Payments to Doctors
See all physicians who received payments from Myriad Genetic Laboratories, Inc.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology